Month: September 2024

Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Written by Customer Service on September 26, 2024. Posted in Public Companies.

— Single patient in 2mg cohort with stage 3 colon cancer who received 4 prior lines of therapy achieves prolonged stable disease and remains on drug into 6th dosing cycle — — No treatment-related adverse events (TRAEs) or dose-limiting toxicities (DLTs) observed to date, including no rash or gastrointestinal (GI) AEs — — Systemic exposure at steady-state enables constant target inhibition while avoiding peak plasma toxicities — — Half-life of approximately 70 hours supports once-daily or less frequent oral dosing — — Distinctive MEK inhibitor profile for the treatment of both NF1-related plexiform and cutaneous neurofibromas, cancer, and other opportunities — MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”),...

ForFarmers sharpens its sustainability ambitions for a future-proof agricultural sector

Written by Customer Service on September 26, 2024. Posted in Public Companies.

Lochem, 26 September 2024 ForFarmers sharpens its sustainability ambitions for a future-proof agricultural sector ForFarmers is committed to future-proof farming through knowledge, advice, support and products on farm. Sustainability plays an essential role in this and is therefore a fundamental part of its mission ‘For the Future of Farming’. In that context, ForFarmers has further sharpened its sustainability ambitions to be able to support farmers and chain partners in the sector’s transition. ForFarmers aims to reduce its own CO2 emissions by one-third by 2030 compared to the year 2022. In addition, ForFarmers aims to increase the use of circular raw materials by one-third and is committed to protecting biodiversity. One-third reduction of CO2 emissions ForFarmers aims to reduce CO2 emissions from its own operations by...

Hut 8 GPU-as-a-Service Vertical Goes Live with Inaugural Deployment

Written by Customer Service on September 26, 2024. Posted in Public Companies.

1,000 NVIDIA H100 GPUs delivered to AI cloud developer Miami, FL, Sept. 26, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, today announced that its GPU-as-a-service vertical has begun generating revenue as the inaugural GPU cluster for an AI cloud developer comes fully online. The cluster, hosted at a tier-three data center in Chicago, comprises multiple Hewlett Packard Enterprise (“HPE”) Cray supercomputers powered by 1,000 NVIDIA H100 GPUs. Hut 8 partnered with HPE and AdvizeX to design, configure, and commission the cluster, which is being launched under Hut 8’s subsidiary, Highrise AI, Inc. Hut 8’s five-year agreement with the AI cloud developer provides...

Hut 8 GPU-as-a-Service Vertical Goes Live with Inaugural Deployment

Written by Customer Service on September 26, 2024. Posted in Public Companies.

1,000 NVIDIA H100 GPUs delivered to AI cloud developer MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, today announced that its GPU-as-a-service vertical has begun generating revenue as the inaugural GPU cluster for an AI cloud developer comes fully online. The cluster, hosted at a tier-three data center in Chicago, comprises multiple Hewlett Packard Enterprise (“HPE”) Cray supercomputers powered by 1,000 NVIDIA H100 GPUs. Hut 8 partnered with HPE and AdvizeX to design, configure, and commission the cluster, which is being launched under Hut 8’s subsidiary, Highrise AI, Inc. Hut 8’s five-year agreement with the AI cloud developer provides for...

Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting

Written by Customer Service on September 26, 2024. Posted in Public Companies.

• Highlights include new safety and efficacy data of Barrigel™ rectal spacer, the first and only sculptable rectal spacer1–3 • Teleflex to host Barrigel™ Educational Symposium featuring a physician panel discussion on the Science of Personalized Spacing with Barrigel™ rectal spacer WAYNE, Pa., Sept. 26, 2024 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced three clinical studies4-6 focused on its Barrigel™ rectal spacer are to be presented at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting, which will take place in Washington, DC, from September 29 to October 2, 2024. The featured data will contribute to the expanding body of clinical evidence regarding the safety and efficacy of Barrigel™ rectal...

REE Automotive Provides Corporate and Business Updates and Reports Second Quarter 2024 Financial Results

Written by Customer Service on September 26, 2024. Posted in Earnings Releases And Operating Results.

$45.35 Million Funding Secured, Strategic Manufacturing Agreement with Motherson, U.S. Production Kicked Off, Continued Demand Drives Orderbook to $60 MillionCompleted $45.35 million Registered Direct offering led by M&G and Motherson securing production capital needs Signed strategic agreement with Motherson, a global automotive supplier, to strengthen REE’s supply chain management and cost structure, improve working capital efficiencies and expand outreach to global OEMs Kicked-off U.S. production in Michigan with Roush as contract manufacturer for full vehicle assembly, with start of production planned for Q4 2024 and deliveries in 2025 Narrowed Q2 2024 net loss by 57% QoQ while concurrently reducing free cash flow burn by 19% QoQ Increased order book by 15% QoQ, and by 289% YoY, which is valued at approximately $60 million to...

Defiance Announces Shift to Weekly Distributions and Name Change for 0DTE Income ETF Suite

Written by Customer Service on September 26, 2024. Posted in Dividend Reports And Estimates.

MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) — Defiance ETFs, a leading innovator in thematic and income-based exchange-traded funds (ETFs), is excited to announce the renaming and strategy update for its suite of Daily Options Income ETFs to better reflect the adoption of same-day expiration options (0DTE) and an enhanced income strategy. Effective September 26th, the following changes have been implemented:Defiance Nasdaq 100 Enhanced Options Income ETF (Ticker: QQQY) has been renamed to Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF. Defiance S&P 500 Enhanced Options Income ETF will now trade under the new ticker symbol WDTE and has been renamed to Defiance S&P 500 Enhanced Options & 0DTE Income ETF. Defiance R2000 Enhanced Options Income ETF (Ticker: IWMY) has been renamed to Defiance R2000 Enhanced...

Global Bispecific Antibodies Clinical Trials Market Size FDA Approved Bispecific Antibodies Insight

Written by Customer Service on September 26, 2024. Posted in Mergers And Acquisitions.

Global Bispecific Antibodies Market Is Estimated To Surpass USD 40 Billion By 2029 Says Kuick Research In Recent Report Delhi, Sept. 26, 2024 (GLOBE NEWSWIRE) — Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) Global Bispecific Antibodies Market Size 2023: > USD 8 Billion Global Bispecific Antibodies Market Forecast Till 2029 Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) Approved Bispecific Antibodies Regional Sales (2018 till 2023) Clinical and Commercial Insight On Approved Bispecific Antibodies: 14 Antibodies Approved Bispecific Antibodies Pricing and Dosage Analysis Global...

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

Written by Customer Service on September 26, 2024. Posted in Public Companies.

PRINCETON, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Ketoconazole Shampoo, 2%. ANI’s Ketoconazole Shampoo, 2% is the generic version of the reference listed drug (RLD) Nizoral®. “We are proud to announce the FDA approval and commercialization of Ketoconazole Shampoo, 2%, another limited competition product. ANI’s talented R&D team continues to execute on our key strategic priority to consistently and effectively launch new products that address the needs of patients,” stated Nikhil Lalwani, President and Chief Executive Officer of ANI. U.S. annual sales for Ketoconazole Shampoo, 2% total approximately...

Descartes Showcases Supply Chain and Logistics Technology Innovations at 2024 Innovation Forum

Written by Customer Service on September 26, 2024. Posted in Public Companies.

ATLANTA and WATERLOO, Ontario, Sept. 26, 2024 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, will showcase supply chain and logistics technology innovations for transportation management; routing, mobile and telematics; and freight forwarders, customs brokers and air cargo at its 2024 Innovation Forum event, which takes place October 8-10, 2024 at the Hyatt Regency O’Hare Chicago. “In a time with many logistical challenges and opportunities, Descartes is focused on bringing leading software solutions and capabilities to market to help our global customer base drive higher levels of supply chain efficiency, security, resilience and competitive advantage,” said Ken Wood, Executive Vice President, Product Management at Descartes....

Month: September 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals